SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) and Astellas Pharma Inc. Announce Initiation of Patient Enrollment in Phase 2 Trial of Tivozanib in Combination With Paclitaxel in Patients With Advanced Triple Negative Breast Cancer
Your Message